[ad_1]
A team of researchers in Montreal is making a diagnostic test for the first time to detect people severely affected by myalgic encephalomyelitis (ME), also known as chronic fatigue syndrome.
This disease is suffered by about 600,000 Canadians and about 2.5 million Americans.
It is a team led by Dr. Alain Moreau, full professor at the Faculty of Dentistry and at the Faculty of Medicine at the University of Montreal, who is behind this advance.
This “allows for the first time to test people severely affected by ME who are not participating in clinical trials due to the severity of their condition,” a news release said Thursday.
The work of the researchers of the CHU Sainte-Justine and the University of Montreal has just been published in the journal “Scientific Reports”.
“The research team is continuing their project to see validation of this test in other populations in order to determine if the biomarkers used here are still as sensitive to detect ME and just as relevant for launching new clinical trials,” we specified. .
“Finally, with the wave of COVID-19, we believe this test will allow early detection of ME in people with persistent post-COVID-19 symptoms and who are very similar to ME in order to be able to intervene early to prevent ME”, he is been added.
Source: journal de montreal – Health
Source link
